Prot# IP107-001: Phase III, Open-Label, Multicenter International Study to Evaluate The Efficacy and Safety of an Octreotide Implant Versus Sandostatin Lar Depot in Patients with Acromegaly

Project: Research project

Project Details

StatusFinished
Effective start/end date12/9/08 → 12/8/11

Funding

  • Pharm-Olam International Ltd. (IP107-001: Phase III)
  • Indevus Pharmaceuticals, Inc. (IP107-001: Phase III)